.PNG&w=256&q=75)
Beta Drugs Limited IPO
NSE SMERs 1,36,000 / 1600 Shares
Beta Drugs Limited IPO Details
The Beta Drugs Limited IPO price band is set between Rs 85 Per Equity Share, with a face value of Rs 10 per share. The issue is managed by Link Intime India Private Ltd, and the equity shares are proposed to be listed on the NSE SME.
The IPO date for subscription opens on 29 Sep, 2017 and closes on 4 Oct, 2017. Investors can check the allotment status on 9 Oct, 2017, while the listing date is tentatively scheduled for 12 Oct, 2017.
The total issue size is 22,96,000 Equity Shares of Rs 10 aggregating up to Rs 19.52 Cr, aggregating up to . Stay tuned for the latest Beta Drugs Limited IPO review and GMP updates.
Beta Drugs Limited IPO Review, Rating & Analysis
Beta Drugs Limited IPO Review
NO REVIEWBeta Drugs Limited IPO Rating
Beta Drugs Limited IPO Highlights
IPO Date
Sep 29, 2017 - Oct 4, 2017
Listing Date
12 Oct, 2017
Face Value
Rs 10 Per Equity Share
Price Band
Rs 85 Per Equity Share
Lot Size
-
Fresh Issue
Shares
Offer for Sale
-
Listing At
NSE SME
Beta Drugs Limited IPO Lot Size
The minimum market lot for Beta Drugs Limited IPO is 1600 shares with an application amount of ₹1,36,000. Retail investors can apply for up to 1 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹1,36,000 |
| Retail (Max) | 1 | 1600 | ₹1,36,000 |
| S-HNI (Min) | 2 | 3200 | ₹2,72,000 |
| S-HNI (Max) | 7 | 11200 | ₹9,52,000 |
| B-HNI (Min) | 8 | 12800 | ₹10,88,000 |
Beta Drugs Limited IPO Timeline
Issue Price
Rs 85 Per Equity ShareFace Value
Rs 10 Per Equity ShareListing at Group
NSE SMERegistrar
Link Intime India Private LtdLead Manager
PANTOMATH CAPITAL ADVISORS PRIVATE LIMITEDIssue Size
22,96,000 Equity Shares of Rs 10 aggregating up to Rs 19.52 CrPromoters & Share Holding
Promoter(s) Name
- Mr Vijay Kumar Batra
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| N/A | N/A |
About Company
Beta Drugs Limited IPO Subscription Details
| As on | QIB/NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 10,83,200 | 10,83,200 | 21,66,400 |
Day 1 -29-09-17 | 0.12 x | 0.05 x | 0.08 x |
Day 2 -03-10-17 | 0.79 x | 0.62 x | 0.70 x |
Day 3 -04-10-17 | 30.05 x | 7.99 x | 19.02 x |
Day 4 -05-10-17 | N/A x | N/A x | N/A x |
Frequently Asked Questions about Beta Drugs Limited IPO IPO
When will Beta Drugs Limited IPO open for subscription?
The Beta Drugs Limited IPO opens on 29 Sep, 2017 and closes on 4 Oct, 2017.
What is the investors portion for Beta Drugs Limited IPO?
The investors' portion for QIB is , NII is N/A, and Retail is 1083200.
How to apply for Beta Drugs Limited IPO?
You can apply for Beta Drugs Limited IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Beta Drugs Limited IPO?
The issue size of Beta Drugs Limited IPO is approx ₹22,96,000 Equity Shares of Rs 10 aggregating up to Rs 19.52 Cr crores.
What is the price band of Beta Drugs Limited IPO?
The price band for Beta Drugs Limited IPO is Rs 85 Per Equity Share to ₹undefined.
What is the lot size of Beta Drugs Limited IPO?
The minimum bid (lot size) for Beta Drugs Limited IPO is 1600 shares with an investment of approx Rs 1,36,000 .
What is the allotment date of Beta Drugs Limited IPO?
The allotment date for Beta Drugs Limited IPO is 9 Oct, 2017.
What is the listing date of Beta Drugs Limited IPO?
The listing date for Beta Drugs Limited IPO is expected to be 12 Oct, 2017.
What is the GMP of Beta Drugs Limited IPO?
The latest Grey Market Premium (GMP) for Beta Drugs Limited IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.